Perrigo (PRGO) Cash from Investing Activities (2013 - 2026)

Perrigo (PRGO) reported Cash from Investing Activities of -$12.4 million for Q1 2026, up 51.75% year-over-year from -$8.2 million in Q1 2025, and up 49.39% quarter-over-quarter from -$24.5 million in Q4 2025.

Perrigo (PRGO) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Cash from Investing Activities data on file, last reported at -$12.4 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$12.4 million, up 51.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$62.1 million (down 181.07% YoY), and the FY2025 annual result was -$75.4 million, down 195.69% from the prior year.
  • Cash from Investing Activities climbed to -$12.4 million in Q1 2026 per PRGO's latest filing, from -$24.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $212.7 million in Q3 2024 and troughed at -$2.0 billion in Q3 2022.
  • A 5-year average of -$120.3 million and a median of -$22.8 million in 2023 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities sank 8956.88% in 2022, then soared 792.83% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$26.0 million in 2022, then grew by 12.31% to -$22.8 million in 2023, then sank by 62.72% to -$37.1 million in 2024, then surged by 33.96% to -$24.5 million in 2025, then soared by 49.39% to -$12.4 million in 2026.
  • Business Quant data shows PRGO's Cash from Investing Activities at -$12.4 million in Q1 2026, -$24.5 million in Q4 2025, and -$21.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Perrigo 1.55 Bn 1.19 Bn 325.50 Mn -12.40 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 -12.40 Mn
Mar 28, 2026 -12.40 Mn
Dec 31, 2025 -24.50 Mn
Dec 31, 2025 -24.50 Mn
Sep 27, 2025 -21.40 Mn
Sep 27, 2025 -21.40 Mn
Jun 28, 2025 -3.80 Mn
Jun 28, 2025 -3.80 Mn
Mar 29, 2025 -25.70 Mn
Mar 29, 2025 -25.70 Mn
Dec 31, 2024 -37.10 Mn
Dec 31, 2024 -37.10 Mn
Sep 28, 2024 212.70 Mn
Sep 28, 2024 212.70 Mn
Jun 29, 2024 -73.30 Mn
Jun 29, 2024 -73.30 Mn
Mar 30, 2024 -23.50 Mn
Mar 30, 2024 -23.50 Mn
Dec 31, 2023 -22.80 Mn
Dec 31, 2023 -22.80 Mn